abediterol   Click here for help

GtoPdb Ligand ID: 9326

Synonyms: LAS-100977
Immunopharmacology Ligand
Compound class: Synthetic organic
Comment: Abediterol (AS100977) is an investigational long-acting beta(β)-agonist (LABA) [1], in development as a once-daily treatment for asthma [2] and potentially COPD. Currently available LABAs approved for use by asthmatic patients include salmeterol, formoterol and olodaterol.
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 4
Hydrogen bond donors 4
Rotatable bonds 13
Topological polar surface area 94.58
Molecular weight 460.22
XLogP 4.54
No. Lipinski's rules broken 1
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES O=c1ccc2c([nH]1)c(O)ccc2C(CNCCCCCCOCC(c1ccccc1)(F)F)O
Isomeric SMILES O=c1ccc2c([nH]1)c(O)ccc2[C@H](CNCCCCCCOCC(c1ccccc1)(F)F)O
InChI InChI=1S/C25H30F2N2O4/c26-25(27,18-8-4-3-5-9-18)17-33-15-7-2-1-6-14-28-16-22(31)19-10-12-21(30)24-20(19)11-13-23(32)29-24/h3-5,8-13,22,28,30-31H,1-2,6-7,14-17H2,(H,29,32)/t22-/m0/s1
InChI Key SFYAXIFVXBKRPK-QFIPXVFZSA-N
No information available.
Summary of Clinical Use Click here for help
Phase 2a first-in-patient clinical trial results are published in [2]. The agent was generally well tolerated, producing a safe, potent, rapid and long-acting bronchodilatory effect in patients with persistent mild-to-moderate asthma.
Mechanism Of Action and Pharmacodynamic Effects Click here for help
LABAs produce long-acting bronchodilatory effect, with clinical utility in managing airway obstruction, for example in asthma and COPD. LABAs are recommended to be used in conjunction with inhaled corticosteroids for asthma management.